These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 35057848)

  • 1. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
    Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
    J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.
    Yao J; Chen X; Liu X; Li R; Zhou X; Qu Y
    Cancer Cell Int; 2021 Jul; 21(1):340. PubMed ID: 34217273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stratification system of ferroptosis and iron-metabolism related LncRNAs guides the prediction of the survival of patients with esophageal squamous cell carcinoma.
    Niu R; Zhao F; Dong Z; Li Z; Li S
    Front Oncol; 2022; 12():1010074. PubMed ID: 36185246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer.
    Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M
    Front Oncol; 2022; 12():780950. PubMed ID: 35280739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
    Wei J; Zeng Y; Gao X; Liu T
    BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.
    Peng J; Hao Y; Rao B; Zhang Z
    Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
    Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
    Front Immunol; 2022; 13():922315. PubMed ID: 35774794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
    Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
    Front Immunol; 2021; 12():783362. PubMed ID: 35154072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
    Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
    BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.
    Pan J; Zhang X; Fang X; Xin Z
    Front Genet; 2021; 12():739470. PubMed ID: 34497636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
    Wang Y; Xu Y; Zhang Y
    Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.
    Li H; Liu L; Huang T; Jin M; Zheng Z; Zhang H; Ye M; Liu K
    Aging (Albany NY); 2021 Oct; 13(19):23072-23095. PubMed ID: 34610581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer.
    Geng H; Qian R; Zhang L; Yang C; Xia X; Wang C; Zhao G; Zhang Z; Zhu C
    Aging (Albany NY); 2022 Aug; 14(15):6358-6376. PubMed ID: 35969182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.
    Li XF; Fu WF; Zhang J; Song CG
    BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.